Page last updated: 2024-09-05

sorafenib and tripalmitin

sorafenib has been researched along with tripalmitin in 1 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (tripalmitin)	Trials (tripalmitin)	Recent Studies (post-2010) (tripalmitin)
6,520	730	5,251	189	4	72

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amore, E; Augello, G; Bondì, ML; Botto, C; Cervello, M; Craparo, EF; Emma, MR	1

Other Studies

1 other study(ies) available for sorafenib and tripalmitin

Article	Year
Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells. International journal of pharmaceutics, 2015, Sep-30, Volume: 493, Issue:1-2 Topics: Antineoplastic Agents; Caprylates; Cell Survival; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Hemolysis; Hep G2 Cells; Humans; Lipids; Microscopy, Electron, Scanning; Nanoparticles; Niacinamide; Particle Size; Phenylurea Compounds; Sorafenib; Triglycerides	2015

Article

Year

Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells.

International journal of pharmaceutics, 2015, Sep-30, Volume: 493, Issue:1-2

Topics: Antineoplastic Agents; Caprylates; Cell Survival; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Hemolysis; Hep G2 Cells; Humans; Lipids; Microscopy, Electron, Scanning; Nanoparticles; Niacinamide; Particle Size; Phenylurea Compounds; Sorafenib; Triglycerides

2015